Jamie Rossjohn

Active 1997–2025

300
Papers
41,876
Citations
121
h-index
287
i10-index

Citations

Citations per year for Jamie Rossjohn1990: 2 citations1994: 1 citations1997: 3 citations1998: 9 citations1999: 21 citations2000: 36 citations2001: 70 citations2002: 64 citations2003: 33 citations2004: 86 citations2005: 153 citations2006: 123 citations2007: 188 citations2008: 233 citations2009: 260 citations2010: 263 citations2011: 308 citations2012: 405 citations2013: 326 citations2014: 455 citations2015: 562 citations2016: 512 citations2017: 462 citations2018: 663 citations2019: 1,628 citations2020: 2,111 citations2021: 1,944 citations2022: 1,445 citations2023: 1,193 citations2024: 1,851 citations2025: 935 citations2026: 50 citations1991–1993: no citations, so these years are not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,735 citing papers, 24.6% of this breakdownChina: 1,380 citing papers, 9.1% of this breakdownUnited Kingdom: 1,334 citing papers, 8.8% of this breakdownAustralia: 1,177 citing papers, 7.8% of this breakdownGermany: 891 citing papers, 5.9% of this breakdownFrance: 660 citing papers, 4.3% of this breakdownCanada: 487 citing papers, 3.2% of this breakdownItaly: 444 citing papers, 2.9% of this breakdownJapan: 429 citing papers, 2.8% of this breakdownNetherlands: 415 citing papers, 2.7% of this breakdownSwitzerland: 325 citing papers, 2.1% of this breakdownSpain: 275 citing papers, 1.8% of this breakdown
0%24.6%Other 24%

Fields

  • Medicine35.8%
  • Immunology and Microbiology34.5%
  • Biochemistry, Genetics and Molecular Biology23.4%
  • Neuroscience1.4%
  • Agricultural and Biological Sciences1%
  • Environmental Science0.7%
  • Other3.2%

Topics

  • Immune Cell Function and Interaction10.5%
  • T-cell and B-cell Immunology8.6%
  • Immunotherapy and Immune Responses5.8%
  • vaccines and immunoinformatics approaches3.1%
  • CAR-T cell therapy research2.9%
  • Monoclonal and Polyclonal Antibodies Research2.2%
  • Other66.9%

Coauthors

All papers

Open in search
  1. Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases

    Authors: , , - Cell 2020 cited by 400

  2. T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules

    Authors: , , , , , - Annual Review of Immunology 2014 cited by 819

  3. MR1 presents microbial vitamin B metabolites to MAIT cells

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 1,363

  4. T-cell activation by transitory neo-antigens derived from distinct microbial pathways

    Authors: , , , , , , , , , , , , , , , , , - Nature 2014 cited by 903

  5. HLA variation and disease

    Authors: , , , - Nature reviews. Immunology 2018 cited by 826

  6. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Randall T. Hayden, Hana Hakim, Diego R. Hijano, Kim Allison, E. Kaitlynn Allen, Resha Bajracharya, Walid H. Awad, Lee-Ann Van de Velde, Brandi L. Clark, Taylor L. Wilson, Aisha Souquette, Ashley Castellaw, Ronald H. Dallas, Ashleigh Gowen, Thomas Fabrizio, Chun-Yang Lin, David C. Brice, Sean Cherry, Ericka Kirkpatrick Roubidoux, Valerie Cortez, Pamela Freiden, Nicholas Wohlgemuth, Kendall Whitt, Joshua Wolf, Sharlene A. Teefey, Jane A. O’Halloran, Rachel M. Presti, Katherine Kedzierska, Jamie Rossjohn, Paul G. Thomas, Ali H. Ellebedy - Cell 2021 cited by 309

  7. More than one reason to rethink the use of peptides in vaccine design

    Authors: , , - Nature Reviews Drug Discovery 2007 cited by 865

  8. The burgeoning family of unconventional T cells

    Authors: , , , , - Nature Immunology 2015 cited by 791

  9. Understanding the drivers of MHC restriction of T cell receptors

    Authors: , , , , - Nature reviews. Immunology 2018 cited by 276

  10. Host immunomodulatory lipids created by symbionts from dietary amino acids

    Authors: , , , , , , , , , , , , , , - Nature 2021 cited by 116

  11. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 598

  12. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Immunity 2023 cited by 107

  13. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2014 cited by 308

  14. Unconventional T Cell Targets for Cancer Immunotherapy

    Authors: , , , , - Immunity 2018 cited by 307

  15. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2016 cited by 366

  16. A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction

    Authors: , , , , , , , , , , , - Briefings in Bioinformatics, Briefings Bioinform. 2019 cited by 184

  17. Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity

    Authors: , , , , , , , , , , , , , , - Nature Communications 2020 cited by 156

  18. mRNA vaccine against malaria tailored for liver-resident memory T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2023 cited by 69

  19. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2015 cited by 383

  20. A multilayered immune system through the lens of unconventional T cells

    Authors: , , , - Nature 2021 cited by 126

  21. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , - Nature Immunology 2017 cited by 250

  22. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

    Authors: , , , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 263

  23. The intracellular pathway for the presentation of vitamin B–related antigens by the antigen-presenting molecule MR1

    Authors: , , , , , , , , , , , - Nature Immunology 2016 cited by 185

  24. Canonical T cell receptor docking on peptide–MHC is essential for T cell signaling

    Authors: , , , , , , , , , , , , , , , , , , , , - Science 2021 cited by 107